AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lapride-MF Tablet ER

Prescription Icon
Prescription Required

Marketer

Lancer Health Care Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Lapride-MF Tablet ER

DiaBeta-Duo ER tablets are classified as antidiabetic medications, combining two active ingredients for adult type 2 diabetes management. This dual-action formulation helps regulate blood glucose. DiaBeta-Duo ER should be administered with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing risks of kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a rapid-acting glucose source. Alcohol consumption should be limited due to its potential to lower blood sugar. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Lapride-MF Tablet ER

Managing type 2 diabetes

Major Benefits of Lapride-MF Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Lapride-MF Extended-Release Tablets should be administered with a meal.

Common Side effects of Lapride-MF Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Lapride-MF Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Lapride-MF Tablet ER with food.

How Lapride-MF Tablet ER works:

Lapride-MF Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Lapride-MF Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Lapride-MF tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Lapride-MF tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Lapride-MF Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Lapride-MF Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Lapride-MF Tablet ER to individuals with hepatic impairment. Dosage modification of Lapride-MF Tablet ER may be necessary. Physician consultation is advised. Initiate Lapride-MF Tablet ER therapy at a reduced dosage for patients exhibiting mild to moderate liver dysfunction; its administration is contraindicated in those with severe hepatic disease.

What if you forget to take Lapride-MF Tablet ER :

Should you forget a Lapride-MF Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lapride-MF Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Lapride-MF Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and ensure it remains inaccessible to children, pets, and others.
Lapride-MF Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Lapride-MF Tablet ER and seek immediate medical attention.
Lapride-MF ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Lapride-MF Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Lapride-MF Tablet ER use can lead to Vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental Vitamin B12 is recommended annually by some researchers.
Lapride-MF Tablet ER can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Lapride-MF Tablet ER and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Lapride-MF Tablet ER
20
MRP 24
16% off